Corporate News

15 May 2023

Rameda Reports its 1Q23 Results
Q1 2023 Download Rameda Earnings

07 Mar 2023

Rameda Reports its FY22 Results
Q4 2022 Download Rameda Earnings

20 Dec 2022

Rameda acquires exclusive rights for the distribution and marketing of “Physiomer” in Egypt
Q4 2022 Download Rameda Earnings

15 Nov 2022

Rameda Reports its 3Q22 Results
Q3 2022 Download Rameda Earnings

21 Aug 2022

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. inaugurates a new high-precision water treatment station
Q3 2022 Download Rameda Earnings

20 Jun 2022

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. joins the UN Global Compact, the world’s largest corporate sustainability initiative.
Q2 2022 Download Rameda Earnings

15 Jun 2022

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. acquires a fast-growing anticonvulsant which grew at 2019-21 CAGR of 226%
Q2 2022 Download Rameda Earnings

23 May 2022

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. acquires fast-growing molecule with an established market presence
Q2 2022 Download Rameda Earnings

17 May 2022

Rameda Partners with IFC to Green its Operations in Egypt
Q2 2022 Download Rameda Earnings

12 May 2022

Rameda Reports its 1Q22 Results
Q1 2022 Download Rameda Earnings

07 Mar 2022

Equinox Pharma Holding Limited (Equinox), alongside other investors, further increases its stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
Q1 2022 Download Rameda Earnings

17 Jan 2022

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. commences the production of antiviral COVID-19 treatment, Molnupiravir Rameda
Q1 2022 Download Rameda Earnings

24 Feb 2022

Rameda Reports its FY21 Results
Q4 2021 Download Rameda Earnings

15 Nov 2021

Rameda Reports its 3Q21 Results
Q3 2021 Download Rameda Earnings

28 Jul 2021

Equinox Pharma Holding Limited (Equinox) increases its stake in Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.
Q3 2021 Download Rameda Earnings

15 Jul 2021

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. acquires a sizeable molecule in a fast-growing therapeutic area
Q3 2021 Download Rameda Earnings

09 Aug 2021

Rameda Reports its 2Q21 Results
Q2 2021 Download Rameda Earnings

06 May 2021

Rameda Reports its 1Q21 Results
Q1 2021 Download Rameda Earnings

27 Jan 2021

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E.’s Chief Executive Officer, Dr. Amr Morsy, recognized among the top 100 Arabian CEOs of 2020
Q1 2021 Download Rameda Earnings

02 Mar 2021

Rameda Reports its FY20 Results
Q4 2020 Download Rameda Earnings

10 Nov 2020

Rameda Reports its 3Q20 Results
Q3 2020 Download Rameda Earnings

20 Jul 2020

Rameda notified of Anviziram, Remdesivir-Rameda vial prices by Egyptian Drug Authority, on track to market first Remdesivir-Rameda production in September 2020
Q3 2020 Download Rameda Earnings

16 Aug 2020

Rameda Reports its 2Q20 Results
Q2 2020 Download Rameda Earnings

22 Jun 2020

Rameda commences manufacture of “Anviziram” Tablets the Generic Equivalent of Japanese antiviral Avigan for treatment of Covid-19 patients and receives approval from Egyptian Drug Authority to manufacture Remedsivir
Q2 2020 Download Rameda Earnings

28 Apr 2020

Rameda issues statement regarding the "Stay Home to Protect your Family and Community" initiative
Q2 2020 Download Rameda Earnings

28 Apr 2020

Rameda values the role played by the Egyptian Pharmacists Syndicate and Pharmacies in serving patients across Egypt
Q2 2020 Download Rameda Earnings

26 Apr 2020

Rameda launches initiative for the complementary dispensary and home delivery of medication at no cost, underlining its dedication to ensuring the healthcare and safety of some of Egypt’s most immune-compromised patient populations amid the COVID-19 pandemic
Q2 2020 Download Rameda Earnings

17 May 2020

Rameda Reports its 1Q20 Results
Q1 2020 Download Rameda Earnings

01 Apr 2020

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Acquires A Large Generic Product in a Sizable and Fast-Growing Therapeutic Area
Q1 2020 Download Rameda Earnings

18 Feb 2020

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Reports double-digit topline growth in FY19 and major facility upgrades & expansions completed during the year
Q4 2019 Download Rameda Earnings

26 Jan 2020

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. Announced Indicative Results for FY2019
Q4 2019 Download Rameda Earnings

11 Dec 2019

Rameda shares begin trading on Egyptian Exchange
Q4 2019 Download Rameda Earnings

27 Nov 2019

Rameda announces the fixed offer price of its IPO on EGX
Q4 2019 Download Rameda Earnings

30 Oct 2019

Rameda announces its intention to float on the Egyptian Exchange
Q4 2019 Download Rameda Earnings

04 Dec 2019

Rameda Reports its 3Q19 Results
Q3 2019 Download Rameda Earnings